Association between new plasma inflammatory markers and risk of colorectal neoplasms in individuals over 50 years old.

IF 3.3 3区 医学 Q2 ONCOLOGY Carcinogenesis Pub Date : 2023-12-30 DOI:10.1093/carcin/bgad064
Jia-Yi Su, Yun Wang, Shang-Shang Wu, Wen-Kun Li, Cheng-Yao Wang, Jiu-Yue Ma, Yu-Ting Qiu, Min-Si Zhou, Zhan Wang, Peng Li, Chun-Tao Liu, Jing Wu
{"title":"Association between new plasma inflammatory markers and risk of colorectal neoplasms in individuals over 50 years old.","authors":"Jia-Yi Su, Yun Wang, Shang-Shang Wu, Wen-Kun Li, Cheng-Yao Wang, Jiu-Yue Ma, Yu-Ting Qiu, Min-Si Zhou, Zhan Wang, Peng Li, Chun-Tao Liu, Jing Wu","doi":"10.1093/carcin/bgad064","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective(s): </strong>The prognostic value of systemic cytokine profiles and inflammatory markers in colorectal cancer were explored by several studies. We want to know more about inflammatory biomarkers in colorectal adenoma and early cancer.</p><p><strong>Method: </strong>The level of 38 inflammatory markers in the plasma of 112 adenoma patients, 72 Tis-T1 staging of colorectal carcinoma patients, 34 T2-T4 staging of colorectal carcinoma patients and 53 normal subjects were detected and compared.</p><p><strong>Result(s): </strong>Eight inflammatory biomarkers (Eotaxin, GCSF, IL-4, IL-5, IL-17E, MCP-1, TNF-α and VEGF-A) have higher plasma concentrations in colorectal adenoma and cancer patients compared with normal participants over 50 years old.</p><p><strong>Conclusion(s): </strong>Inflammatory markers may have the prognostic value for colorectal adenoma and early-stage carcinoma.</p>","PeriodicalId":9446,"journal":{"name":"Carcinogenesis","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Carcinogenesis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/carcin/bgad064","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective(s): The prognostic value of systemic cytokine profiles and inflammatory markers in colorectal cancer were explored by several studies. We want to know more about inflammatory biomarkers in colorectal adenoma and early cancer.

Method: The level of 38 inflammatory markers in the plasma of 112 adenoma patients, 72 Tis-T1 staging of colorectal carcinoma patients, 34 T2-T4 staging of colorectal carcinoma patients and 53 normal subjects were detected and compared.

Result(s): Eight inflammatory biomarkers (Eotaxin, GCSF, IL-4, IL-5, IL-17E, MCP-1, TNF-α and VEGF-A) have higher plasma concentrations in colorectal adenoma and cancer patients compared with normal participants over 50 years old.

Conclusion(s): Inflammatory markers may have the prognostic value for colorectal adenoma and early-stage carcinoma.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
50 岁以上人群新血浆炎症标志物与结直肠肿瘤风险之间的关系。
研究目的多项研究探讨了全身细胞因子谱和炎症标志物在结直肠癌中的预后价值。我们希望进一步了解结直肠腺瘤和早期癌症中的炎症生物标志物:方法:检测并比较 112 名腺瘤患者、72 名 Tis-T1 分期大肠癌患者、34 名 T2-T4 分期大肠癌患者和 53 名正常人血浆中 38 种炎症标志物的水平:结果:8种炎症生物标志物(Eotaxin、GCSF、IL-4、IL-5、IL-17E、MCP-1、TNF-α和VEGF-A)在结直肠腺瘤和癌症患者与50岁以上正常人的血浆中浓度较高:炎症标志物可能对结直肠腺瘤和早期癌具有预后价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Carcinogenesis
Carcinogenesis 医学-肿瘤学
CiteScore
9.20
自引率
2.10%
发文量
95
审稿时长
1 months
期刊介绍: Carcinogenesis: Integrative Cancer Research is a multi-disciplinary journal that brings together all the varied aspects of research that will ultimately lead to the prevention of cancer in man. The journal publishes papers that warrant prompt publication in the areas of Biology, Genetics and Epigenetics (including the processes of promotion, progression, signal transduction, apoptosis, genomic instability, growth factors, cell and molecular biology, mutation, DNA repair, genetics, etc.), Cancer Biomarkers and Molecular Epidemiology (including genetic predisposition to cancer, and epidemiology), Inflammation, Microenvironment and Prevention (including molecular dosimetry, chemoprevention, nutrition and cancer, etc.), and Carcinogenesis (including oncogenes and tumor suppressor genes in carcinogenesis, therapy resistance of solid tumors, cancer mouse models, apoptosis and senescence, novel therapeutic targets and cancer drugs).
期刊最新文献
Correction to: Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer. CAFomics: convergence to translation for precision stroma approaches. Exogenous or in situ vaccination to trigger clinical responses in pancreatic cancer. From precursor to cancer: decoding the intrinsic and extrinsic pathways of pancreatic intraepithelial neoplasia progression.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1